The biotechnology industry is characterized by a network structure of interorganizational
relationships that acts as a coordination device between a variety of actors–new …

This paper addresses the conditions that enable new biotechnology firms (NBF) operating
outside major biotechnology clusters, to obtain the resources and competences necessary …

This chapter addresses the strategies adopted by new biotechnology firms (NBFs), located
outside major concentrations of biotechnology knowledge and business, to access scientific …

This paper develops and tests hypotheses related to the aggregated effect of geographic
clustering and cooperation networks positively affects the innovation performance. It is …

The mode of organization adopted in the early stages effectively shaped the development of
the industry (Powell et al. forthcoming; McKelvey 2008). It led to the emergence of a new …

The dynamic growth of biotechnology in Germany in recent years has an obviously spatial
pattern. Some regions show a substantial potential for start-ups and young firms of this new …

Differences in growth patterns between regional clusters are often attributed to the extent to
which they benefit from agglomeration, defined as the advantages that derive from being …

The nature, frequency and outcomes of inter-firm networks in high-tech clusters form a key
element in the debate about the link between innovation, firm competitiveness and regional …

This paper focuses on the characteristics of biotech firms with various levels of research and
development (R&D) activity. It is done by exploring the relationship between R&D intensity …

Abstract Knowledge-intensive industries tend to concentrate geographically, because of the
many spillovers that they generate. Thus new biotechnology firms often set up in regions that …